BioSpace News Archive

Advarra, the market leader in practice management technology for clinical research and regulatory review solutions, today kicked off Onsemble, the premier conference for the research community, which is held over four days.

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, based on its patented biophotonic technology, announced today that its Chinese partner, Shandong Yaohua Medical Instrument Corporation (SMI), had received ethics board approval and placed LuViva devices at two of the three participating hospitals for clinical trials aimed at achieving Chinese FDA approval.

GNS Healthcare (GNS), an artificial intelligence company creating in silico patients that simulate drug treatment at the individual patient level, today announced a multi-year collaboration with Memorial Sloan Kettering Cancer Center (MSK) to leverage longitudinal multi-modal prostate cancer patient data and world class prostate cancer expertise with GNS’ Gemini in silico Prostate Cancer patient.

On October 21th at 9AM PST / 12PM EST , Dr. Kelly Wosnik , Owner/ NP-C of Bristol Health will share practice patterns and associated clinical implications using pharmacogenomic testing (PGx) to pinpoint the right treatments for mental illnesses.

Colospan which develops novel solutions for colorectal surgery, announced today the appointment of Gregory D. Casciaro to its board of directors.

BioCina, a leading contract development and manufacturing organization specializing in process development and cGMP manufacturing of microbial-based therapeutics and mRNA vaccines announces the full and final transition from Hospira Adelaide Pty Ltd., an affiliate of Pfizer Inc., of its biologics manufacturing facility, colleagues and operations in Adelaide, Australia.

Carbon Health, a leading national healthcare provider, today announced the acquisition of Alertive Healthcare, an industry-leading remote patient monitoring (RPM) company.

Zivo Bioscience, Inc., a biotech/agtech R&D company engaged in the development and commercialization of therapeutic, medicinal and nutritional product candidates originally derived from proprietary algal cultures, issues a notice to its shareholders concerning the annual shareholder meeting.

Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), today announced that management will be presenting at the H.C. Wainwright 5th Annual NASH Investor Conference.

Today, Boston Scientific (NYSE: BSX) announced positive results for the EkoSonic™ Endovascular System (EKOS system) during a late-breaking clinical trial presentation at the Vascular InterVentional Advances (VIVA) meeting in Las Vegas.